Adults taking the highest approved dose of tirzepatide lost an average of 22.5 percent of their body weight in clinical trials, while those on the highest dose of semaglutide averaged closer to 13.7 to 18 percent, depending on the specific trial and dose. Numbers like these are exactly why GLP-1 medications have become the most requested weight management option we see at Lumea Med Spa, and also why so many clients arrive at their first consultation with genuine confusion about which medication actually fits their situation.
Semaglutide isn’t a shortcut, and it isn’t right for everyone. But for the right candidate, it represents a meaningfully different approach to weight management than diet and exercise alone, one grounded in real clinical trial data rather than wellness industry marketing.
This blog post walks through how semaglutide actually works, what real results look like, the honest safety picture, and how it stacks up against tirzepatide, the other GLP-1 medication clients ask about most.
What Semaglutide Actually Is
Semaglutide is a GLP-1 receptor agonist, meaning it mimics a hormone your gut naturally produces called glucagon-like peptide-1. This hormone plays a role in regulating appetite, slowing how quickly food moves through your stomach, and signaling fullness to your brain.
The FDA approved semaglutide for chronic weight management under the brand name Wegovy in 2021, for adults with obesity or with overweight plus at least one weight related health condition like high blood pressure or high cholesterol. A higher dose formulation, Wegovy HD, received approval more recently and has shown weight loss results approaching those seen with tirzepatide in head to head style trial comparisons.
Semaglutide is administered as a once weekly injection under the skin, typically in the abdomen, thigh, or upper arm, with the dose increased gradually over several weeks to reduce side effects before reaching a target maintenance dose.
How Semaglutide Works for Weight Loss
Semaglutide’s appetite suppressing effect comes from acting on GLP-1 receptors in the brain regions that regulate hunger and satiety, while simultaneously slowing gastric emptying so food sits in your stomach longer. The combined effect is that most patients simply feel full sooner and stay full longer between meals.
This isn’t a mechanism that works instantly. Most clients notice a genuine shift in appetite within the first few weeks, with the effect becoming more pronounced as the dose increases during the titration period. Weight loss tends to be gradual and consistent rather than dramatic in the first week, which is part of why real results require staying with the medication and the dosing schedule for months, not weeks.
What Real Results Look Like
Clinical trial data gives the most honest picture of what to expect, and it’s worth looking at directly rather than relying on secondhand claims.
In trials studying long term use, average weight loss with standard dose Wegovy has landed in the 15 to 17 percent range of total body weight over roughly a year of consistent treatment, with the newer higher dose Wegovy HD showing results closer to 21 percent in more recent trial data. These are averages across large groups of patients, meaning individual results vary considerably based on starting weight, adherence, dose, and how your body responds to the medication specifically.
It’s worth being direct that semaglutide, like every weight loss medication, doesn’t work the same for everyone. Some patients see results at the lower end of the reported range, and a small percentage don’t respond meaningfully at all, which is exactly why ongoing monitoring and dose adjustment with your provider matters throughout treatment rather than assuming a single starting dose is the right long term fit.
Semaglutide vs. Tirzepatide for Weight Loss in Miami
This is one of the most common questions we field in weight loss consultations, and it deserves a direct answer grounded in the actual head to head data.
Tirzepatide, sold under the brand name Zepbound for weight management, works on two hormone pathways instead of one. In addition to the GLP-1 receptor that semaglutide targets, tirzepatide also activates GIP receptors, a second gut hormone involved in insulin regulation and fat metabolism. The theory, supported by trial data, is that hitting both pathways produces a stronger effect than targeting GLP-1 alone.
The head to head SURMOUNT-5 trial, which directly compared the two medications, found that participants lost an average of 20.2 percent of body weight on tirzepatide compared to 13.7 percent on semaglutide over the same treatment period. Earlier trials comparing the highest approved doses of each medication showed a similar pattern, with tirzepatide averaging around 22.5 percent body weight loss compared to semaglutide’s 13.7 to 18 percent range depending on formulation and dose.
That said, tirzepatide isn’t automatically the better choice for every patient. Semaglutide, under the Wegovy brand, carries FDA approval specifically for reducing cardiovascular risk, including heart attack, stroke, and cardiovascular death, in patients with established heart disease and obesity or overweight. Tirzepatide’s cardiovascular outcomes data is still being studied and doesn’t currently carry that same approved indication. Tirzepatide does hold a specific approval for obstructive sleep apnea in adults with obesity, an indication semaglutide doesn’t currently have.
Cost, side effect tolerance, and how your body responds also factor into which medication makes more sense for you individually. Stomach related side effects, including nausea, diarrhea, and vomiting, tend to be somewhat more pronounced with tirzepatide, particularly at higher doses, which is a real consideration for patients who are especially sensitive to gastrointestinal side effects.
Side Effects and Safety Considerations
Semaglutide’s most common side effects are gastrointestinal: nausea, diarrhea, vomiting, constipation, and abdominal discomfort, particularly during the dose escalation period as your body adjusts. These effects generally ease over time and tend to be most noticeable right after a dose increase.
Semaglutide carries a boxed warning, the FDA’s strongest safety warning, regarding a potential risk of thyroid tumors based on findings in animal studies. It’s currently unknown whether this risk translates to humans, but the medication should not be used by anyone with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.
Other considerations include a risk of pancreatitis, gallbladder problems, and low blood sugar when combined with certain other medications. Semaglutide also slows gastric emptying, which matters for anyone with a history of severe gastroparesis and for anyone with upcoming procedures requiring anesthesia, since slowed digestion can affect anesthesia safety protocols.
None of this makes semaglutide inappropriate for the right candidate. It does mean a thorough medical history and honest conversation about your specific risk factors needs to happen before starting, which is a non negotiable part of how we approach every weight loss consultation.
Who Tends to Be a Good Candidate
Semaglutide for weight management is approved for adults with a body mass index of 27 or higher who also have at least one weight related health condition, or a BMI of 30 or higher regardless of other conditions. Beyond the numbers, good candidates are typically those who’ve had genuine difficulty achieving sustainable results through diet and exercise alone and who are prepared for an ongoing treatment relationship, not a short term fix.
Semaglutide isn’t approved or appropriate for pregnant or breastfeeding individuals, and anyone with a personal or family history of certain thyroid cancers should not use it. A thorough intake covering your full medical history, current medications, and specific goals is how we determine candidacy, not a quick questionnaire.
Setting Realistic Expectations for the First Few Months
The dose escalation period, typically the first four to twenty weeks depending on the medication and your individual response, is where most patients experience the most noticeable side effects and the least dramatic weight loss. Knowing this upfront prevents the discouragement that comes from expecting fast results and instead getting an adjustment period.
Around week eight to twelve, most clients report a clear shift, appetite feels genuinely different, portion sizes shrink without much conscious effort, and the scale starts moving more consistently. This is also typically when your dose reaches a level closer to your eventual maintenance dose, assuming your provider has been titrating you upward as planned.
Plateaus are normal and don’t necessarily mean the medication has stopped working. Weight loss on GLP-1 medications often happens in phases rather than a perfectly straight line, and a stretch of several weeks with less movement on the scale is common and generally not a reason to panic or assume something’s wrong.
Cost and Insurance Considerations
Insurance coverage for semaglutide varies enormously depending on your specific plan, your diagnosis, and whether your insurer covers weight management medications at all. Many commercial plans still classify GLP-1 medications prescribed purely for weight loss as a non covered benefit, even when they’ll cover the same medication for type 2 diabetes.
Manufacturer savings programs can meaningfully reduce out of pocket costs for patients with commercial insurance, though eligibility rules and savings caps apply and change periodically. Cash pricing without any insurance or savings program assistance remains a genuine barrier for many patients, which is worth discussing openly during your consultation rather than discovering after you’ve already committed to a plan.
Budgeting realistically for ongoing treatment, not just the first month, matters since this is generally a sustained commitment rather than a short course. We walk through the actual expected cost of your specific plan before you start, not just the price of the first prescription.
How This Differs From Our Broader Weight Loss Program
Semaglutide is one tool within a complete weight management approach, not a standalone fix disconnected from everything else. Our weight loss program combines GLP-1 medication, when appropriate, with the lifestyle support, monitoring, and adjustment that meaningfully affects how well results hold up over time.
We’ve written previously about how a medically supervised program differs from unsupervised, DIY approaches to weight loss in our piece on medical weight loss versus DIY approaches, which goes deeper into why supervision and adjustment matter as much as the medication itself.
What This Looks Like at Lumea
At Lumea Med Spa, semaglutide treatment starts with a real evaluation of your health history, goals, and candidacy, not a prescription handed out based on a BMI number alone. We monitor your progress and adjust your plan as you move through treatment, rather than setting a dose once and disappearing until your next refill.
Our Kendall based team treats weight loss as an ongoing medical relationship, which means regular check ins, honest conversations about what’s working, and adjustments when something isn’t.
Schedule a consultation with our team to find out whether semaglutide, tirzepatide, or a different approach entirely fits your specific situation.
Frequently Asked Questions
How quickly will I lose weight on semaglutide?
Most patients see gradual, consistent weight loss over months rather than a dramatic initial drop, with results building as your dose increases during the titration period over the first several weeks.
Do I have to stay on semaglutide forever?
Semaglutide is generally studied and used as a long term treatment for chronic weight management, and many patients regain some weight after stopping. Whether long term use makes sense for you is a conversation to have directly with your provider based on your specific goals and response to treatment.
Can I switch from semaglutide to tirzepatide, or the reverse?
Switching between GLP-1 medications does happen, but it should be done under medical supervision rather than independently, since dosing and titration differ between the two.
Is semaglutide safe to use with other medications?
It can slow how your body absorbs other oral medications due to its effect on digestion, so a full medication review with your provider before starting is important, not optional.
Will I need to change my diet while taking semaglutide?
Most providers recommend pairing treatment with reasonable dietary changes, focusing on adequate protein and nutrient dense foods, since appetite suppression alone doesn’t guarantee you’re eating in a way that supports muscle mass and overall health during weight loss.
Sources
FDA Approves New Medication for Chronic Weight Management (Zepbound/tirzepatide), U.S. Food and Drug Administration: https://www.fda.gov/news-events/press-announcements/fda-approves-new-medication-chronic-weight-management
Tirzepatide vs semaglutide: How do they compare?, Drugs.com: https://www.drugs.com/medical-answers/tirzepatide-semaglutide-how-compare-3576410/
